Schrödinger (SDGR)
Builds physics-based software for molecular design and uses it in drug discovery.
$30.28
After-hours close−0.42 (−1.37%)
At close$30.70(+1.52%)
In millions of USD, except per-share figures
| In millions | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 43 | 74 | 37 | 47 | 35 | 88 | 60 | 55 | 54 | 87 | 59 | 59 |
| Cost of revenue | 19 | 17 | 18 | 16 | 18 | 24 | 28 | 29 | 26 | 30 | 29 | 26 |
| Gross profit | 24 | 58 | 19 | 31 | 18 | 64 | 31 | 26 | 28 | 57 | 30 | 32 |
| 80 | 87 | 86 | 84 | 86 | 85 | 82 | 79 | 74 | 74 | 78 | 74 | |
| Research & development | 47 | 51 | 51 | 51 | 51 | 49 | 46 | 43 | 43 | 41 | 44 | 41 |
| 33 | 36 | 36 | 33 | 35 | 35 | 36 | 36 | 31 | 33 | 35 | 33 | |
| Selling & marketing | 9 | 10 | 10 | 10 | 10 | 10 | 10 | 11 | 10 | 10 | 12 | 10 |
| General & administrative | 24 | 26 | 26 | 24 | 25 | 26 | 26 | 25 | 22 | 23 | 23 | 23 |
| Operating income | −56 | −30 | −67 | −53 | −68 | −21 | −51 | −53 | −46 | −17 | −49 | −42 |
| −9 | −2 | 13 | −1 | 30 | −19 | −9 | 10 | 13 | 50 | −11 | 49 | |
| Other non-operating income | 0 | 2 | −13 | 1 | −30 | 19 | 9 | −10 | −13 | −50 | 11 | −49 |
| Income before tax | −65 | −32 | −54 | −54 | −38 | −39 | −60 | −43 | −33 | 33 | −60 | 7 |
| Income tax expense | −3 | −1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 |
| Net income from continuing operations | −62 | −31 | −55 | −54 | −38 | −40 | −60 | −43 | −33 | 33 | −60 | 6 |
| Net income | −62 | −31 | −55 | −54 | −38 | −40 | −60 | −43 | −33 | 33 | −60 | 6 |
| EPS, basic | −$0.86 | −$0.43 | −$0.76 | −$0.74 | −$0.52 | −$0.55 | −$0.82 | −$0.59 | −$0.45 | $0.44 | −$0.81 | $0.08 |
| EPS, diluted | −$0.86 | −$0.43 | −$0.76 | −$0.74 | −$0.52 | −$0.55 | −$0.82 | −$0.59 | −$0.45 | $0.44 | −$0.81 | $0.08 |
| Weighted average shares, basic | 72 | 72 | 72 | 73 | 73 | 73 | 73 | 73 | 74 | 73 | 74 | 75 |
| Weighted average shares, diluted | 72 | 72 | 72 | 73 | 73 | 73 | 73 | 73 | 74 | 73 | 74 | 76 |
| EBITDA | −55 | −30 | −53 | −53 | −37 | −37 | −58 | −41 | −31 | 36 | −58 | 7 |
| Depreciation & amortization | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 1 | 3 | 1 | 0 |
| EBIT | −56 | −32 | −54 | −54 | −38 | −39 | −60 | −43 | −33 | 33 | −60 | 7 |
